Skip to main content
Top
Published in: Rheumatology International 2/2004

01-03-2004 | Original Article

Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis

Authors: Salih Ozgocmen, Sadık Sogut, Ozge Ardicoglu, Ersin Fadillioglu, Irfan Pekkutucu, Omer Akyol

Published in: Rheumatology International | Issue 2/2004

Login to get access

Abstract

In this study, serum antioxidant and oxygen derived free radical status of patients with ankylosing spondylitis (AS) was investigated and compared with that of age- and sex-matched healthy controls. The relationship of these parameters to disease activity indices was also examined. Thirty patients with AS not currently under disease-modifying antirheumatic drug (DMARD) treatment (e.g., sulfasalazine or methotrexate) (15 active and 15 inactive) and 16 age- and sex-matched healthy controls were included in the study. Catalase (EC 1.11.1.6), total (Cu-Zn and Mn) superoxide dismutase (SOD) (EC 1.15.1.1) activities, and malondialdehyde (MDA), nitrite (NO2 -), and nitrate (NO3 -) levels as indices of nitric oxide (NO) production were evaluated using appropriate methods. There was no statistically significant difference found in SOD activity or NO and MDA levels between active and inactive patients. Inactive patients showed no significant difference in all the measured oxidant/antioxidant parameters when compared to healthy controls. Active patients had significantly higher levels of MDA and catalase enzyme activity (P=0.002 and P=0.007, respectively). There was no significant correlation between oxidant/antioxidant parameters and disease activity, C-reactive protein, erythrocyte sedimentation rate, or Bath Ankylosing Spondylitis Disease Activity Index (CRP, ESR, or BASDAI) in either group, except catalase enzyme activity, which had a significant correlation with CRP and ESR levels in active patients (r=0.69 and P=0.004, r=0.52 and P=0.04, respectively). Our results indicate that oxidative stress and lipid peroxidation are accelerated in untreated patients with active AS. Serum catalase activity may be closely related to disease activity. In this regard, we underscore the likely benefit of some therapeutic interventions including high-potential antioxidants that will potentiate the antioxidant defense mechanism and reduce peroxidation in the management of AS.
Literature
1.
go back to reference Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel J, Dieppe P (eds) Rheumatology. Mosby Year Book Europe, London, 3:25.1–3.25.10 Khan MA (1994) Ankylosing spondylitis: clinical features. In: Klippel J, Dieppe P (eds) Rheumatology. Mosby Year Book Europe, London, 3:25.1–3.25.10
2.
go back to reference Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R et al (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1:289–293PubMed Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R et al (1989) Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1:289–293PubMed
3.
go back to reference Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed Lunec J, Halloran SP, White AG, Dormandy TL (1981) Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 8:233–245PubMed
4.
go back to reference Imadaya A, Terasawa K, Tosa H, Okamoto M, Toriizuka K (1988) Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed Imadaya A, Terasawa K, Tosa H, Okamoto M, Toriizuka K (1988) Erythrocyte antioxidant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed
5.
go back to reference Abella A, Clerc D, Chalas J, Baret A, Leluc R, Lindenbaum A (1987) Concentration en superoxyde dismutase (cuivre et manganèse), catalase et glutathion peroxydase dans les hématies, les plaquettes et le plasma de sujets atteints de polyarthrite rhumatoïde. Ann Biol Clin 45:152–155 Abella A, Clerc D, Chalas J, Baret A, Leluc R, Lindenbaum A (1987) Concentration en superoxyde dismutase (cuivre et manganèse), catalase et glutathion peroxydase dans les hématies, les plaquettes et le plasma de sujets atteints de polyarthrite rhumatoïde. Ann Biol Clin 45:152–155
6.
go back to reference Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355CrossRefPubMed Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355CrossRefPubMed
7.
go back to reference Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597PubMed Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597PubMed
go back to reference 8-Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMed 8-Wendling D, Didier JM, Vuitton DA (1991) The phagocyte oxidative metabolism function in ankylosing spondylitis. Rheumatol Int 11:187–189PubMed
9.
go back to reference Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, et al (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, et al (1995) Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients. Clin Exp Rheumatol 13:623–627PubMed
10.
go back to reference Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341CrossRefPubMed Ho KJ, Chen PQ, Chang CY, Lu FJ (2000) The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 59:338–341CrossRefPubMed
11.
go back to reference Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMed Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMed
12.
go back to reference Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Daugados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882 Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Daugados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38:878–882
13.
go back to reference Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 673–677 Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 673–677
14.
go back to reference Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed
15.
go back to reference Wasowicz W, Neve J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526PubMed Wasowicz W, Neve J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522–2526PubMed
16.
go back to reference Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443PubMed Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443PubMed
17.
go back to reference Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151CrossRefPubMed Clancy RM, Amin AR, Abramson SB (1998) The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141–1151CrossRefPubMed
18.
go back to reference Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed
19.
go back to reference Malinski T, Taha Z (1992) Nitric oxide release form a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676–678 Malinski T, Taha Z (1992) Nitric oxide release form a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676–678
20.
go back to reference Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H et al (2000) Testicular nitric oxide levels after unilateral testicular torsion-detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 28:360–363PubMed Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H et al (2000) Testicular nitric oxide levels after unilateral testicular torsion-detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 28:360–363PubMed
21.
go back to reference Sahin S, Sogut S, Ozyurt H, Uz E, Ilhan A, Akyol O (2002) Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111–121CrossRef Sahin S, Sogut S, Ozyurt H, Uz E, Ilhan A, Akyol O (2002) Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111–121CrossRef
22.
go back to reference Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondylarthropathies. Br J Rheumatol 34:616–619PubMed Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frolich JC (1995) Elevated serum nitrate concentrations in active spondylarthropathies. Br J Rheumatol 34:616–619PubMed
23.
go back to reference Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulfasalazine. Br J Rheumatol 26:202–206PubMed Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulfasalazine. Br J Rheumatol 26:202–206PubMed
24.
go back to reference Toth KM, Berger EM, Beehler CJ, Repine JE (1986) Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am J Respir Dis 134:281–284 Toth KM, Berger EM, Beehler CJ, Repine JE (1986) Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am J Respir Dis 134:281–284
25.
go back to reference Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M et al (2001) The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 68:311–317CrossRef Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M et al (2001) The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 68:311–317CrossRef
Metadata
Title
Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis
Authors
Salih Ozgocmen
Sadık Sogut
Ozge Ardicoglu
Ersin Fadillioglu
Irfan Pekkutucu
Omer Akyol
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2004
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0335-y

Other articles of this Issue 2/2004

Rheumatology International 2/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.